Pharmacogenomics: The path to individualised patient care

British Journal of Nursing

Volumn 23, Issue 13, 2014, Pages 738-739

  Adelung, Mark R ^a,b   Fitzsimons, Virginia M ^b  

^a Ocean County College   (United States)

^b KEAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ADVERSE DRUG REACTION; ARTICLE; DRUG HYPERSENSITIVITY; GENETICS; HUMAN; PERSONALIZED MEDICINE; PHARMACOGENETICS; UNITED KINGDOM;

DRUG HYPERSENSITIVITY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GREAT BRITAIN; HUMANS; INDIVIDUALIZED MEDICINE; PHARMACOGENETICS; PRESCRIPTION DRUGS;

EID: 84906928872     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2014.23.13.738     Document Type: Note

References (20)

1. Badzek L, Turner M, Jenkins JF (2008) Genomics and nursing practice: Advancing the nursing profession. The Online Journal of Issues in Nursing 13(1): doi:10.3912/OJIN.Vol13No01Man01
2. Calzone KA, Jenkins J (2012) Genomics education in nursing in the United States. In: Pepper GA, Wysocki KJ, Kasper, CE, eds, Annual Review of Nursing Research Volume 29: Genetics. Springer Publishing Co, New York: 151-72
3. Calzone KA, Cashion A, Feetham S et al (2010). Nurses transfroming health care using genetics and genomics. Nursing Outlook 58: 26-35
4. Centre for Genetics Education (2013) Fact sheet 25: Pharmacogenetics/pharmacogenomics. http://tinyurl.com/ljaae26 (accessed 1 July 2014)
5. Crews K, Hicks JK, Pui C, Relling MV, Evans WE (2012). Pharmacogenomics and individualized medicine: Translating science into practice. Clin Pharmacol Ther 92(4): 467-75. doi: 10.1038/clpt.2012.120.
6. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M (2009). Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. PLOS ONE. doi:10.1371/journal.pone.0004439
7. Duke Center for Personalized and Precision Medicine (2013) Pharmacogenomics http://tinyurl.com/qgarc3k (accessed 1 July 2014)
8. European Medicines Agency (2012) European Public Assessment Report: Ziagen. http://tinyurl.com/q3q5qza (accessed 3 July 2014)
9. Genetics Home Reference (2014) What is pharmacogenomics? http://tinyurl.com/p3xsonb (accessed 1 July 2014)
10. Howington L, Riddlesperger K, Cheek D (2011) Essential nursing competencies for genetics and genomics: implications for critical care. Crit Care Nurse 31(5): e1-7. doi: 10.4037/ccn2011867.
11. The Jackson Laboratory for Genomic Medicine (2014) Personalized medicine and genomics. http://tinyurl.com/l8e5kc2 (accessed 1 July 2014)
12. Jonas DE, Wines R (2013) Pharmacogenomic testing and the prospect of individualized treatment. N C Med J 74: 485-93
13. National Human Genome Research Institute (2014) Frequently Asked Questions About Genetic and Genomic Science http://www.genome.gov/19016904
14. PharmGKB (2014a) European Medicines Agency (EMA) Label for abacavir and HLA-B. http://tinyurl.com/o9rj2an (accessed 2 July 2014)
15. PharmGKB (2014b) European Medicines Agency (EMA) Label for mercaptopurine and TPMT. http://tinyurl.com/mdwr9vc (accessed 3 July 2014)
16. Scibona P, Angiman F, Vazquez C et al (2014) Individualization of drug therapy in older people. Reviews in Clinical Gerontology 24 (2): 145-57. doi:10.1017/s0959259814000033
17. Shah R, Shah D (2012) Personalized medicine: is it a pharmacogenetic mirage? Br J Clin Pharmacol 74(4): 698-721. doi: 10.1111/j.1365-2125.2012.04328.x.
18. Vail J (2007) Pharmacogenomics: The end of trial-and-error medicine? Int J Pharm Compd 11(1): 59-65
19. Wheeler HE, Maitland ML, Dolan ME, Cox NJ, Ratain MJ (2013) Cancer pharmacogenomics: strategies and challenges. Nat Rev Genet 14(1):23-34. doi: 10.1038/nrg3352. Epub 2012
20. Wilkinson JM, Treas LS (2011) Fundamentals of Nursing. 2nd edn. FA Davis Company, Philadelphia